Expert Advice on Coronavirus Risk in Immunocompromised Patients With Rheumatic Diseases
Doug Roberts, MD, discusses the effect that the novel coronavirus could have in patients who are immunocompromised with rheumatic diseases.
All articles by Meghna Rao
EULAR Develops Points to Consider for Big Data Analysis and Use in Rheumatic and Musculoskeletal Diseases
The European League Against Rheumatism developed recommendations for the collection, analysis, and use of big data in rheumatic and musculoskeletal disorders.
A Vision for Lupus Develops Calls to Action to Improve Quality of Lupus Care
Patricia Cagnoli, MD, discusses the current gaps in lupus care and A Vision for Lupus initiative that aims to raise awareness and improve access to healthcare for patients with lupus.
Discordance Between Patient or Family and Physician Assessments Common in Juvenile Dermatomyositis
Researchers measured discordance between patient or family and physician global activity scores in juvenile dermatomyositis, and determined factors associated with discordance.
Effect of Intra-Articular Treatment on Patient-Reported Outcomes in Knee Osteoarthritis
Yusuf Yazici, MD, discussed the effect of the intra-articular inhibitor treatment, lorecivivint, on patient-reported outcomes in patients with knee osteoarthritis.
A Closer Look at Biomarker-Based Disease Activity Measures in RA
In this Q&A, Dr Jeffery R Curtis discusses the applications of the multibiomarker disease activity Vectra® test in measuring rheumatoid arthritis disease activity.
Updated 2019 ACR Recommendations for Rheumatoid Arthritis Disease Activity Measures
The 2019 update of the American College of Rheumatology recommendations on disease activity measurements in rheumatoid arthritis was recently released.
Ixekizumab Superior to Placebo in Improving Symptoms, Inflammation in Nonradiographic Axial Spondyloarthritis
In a phase 3 study, researchers assessed the efficacy and safety of ixekizumab in patients with active nonradiographic axial spondyloarthritis.
2019 ACR/ARP Annual Meeting: What You Can Expect
The first report of the sessions and presentations scheduled to take place at the 2019 ACR/ARP Annual Meeting, being held November 8 to 13 in Atlanta, Georgia.
Interstitial Lung Disease Associated With More Muscle Mass, Less Bone Density Loss
Researchers of the study aimed to determine the differences in muscle area and bone density in patients with end-stage lung disease.
-
Loading...
-
Loading...
Next post in General Rheumatology
